Befejeződött1. fázis
A trial to find out how well CVHNLC works at different dose levels and how safe it is in combination with pembrolizumab in patients with lung cancer that cannot be completely cured.
Key facts
- Where
- Bordeaux, Marseille, Paris, Rennes, Saint-Herblain Cedex, Toulouse és Villejuif, FranciaországSee the 7 sites
- Phase
- 1. fázis
Where in Franciaország
- Institut BergonieBordeaux, FranciaországNo longer taking part
- Centre Hospitalier Regional De MarseilleMarseille, FranciaországNo longer taking part
- Institut CurieParis, FranciaországNo longer taking part
- Centre Hospitalier Universitaire de RennesRennes, FranciaországNo longer taking part
- Institut De Cancerologie De L OuestSaint-Herblain Cedex, FranciaországNo longer taking part
- Oncopole Claudius RegaudToulouse, FranciaországNo longer taking part
- Institut Gustave RoussyVillejuif, FranciaországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- CureVac SE
- Trial code
- EU 2024-519651-28-00
- Record updated
- 2025. június 4.